Literature DB >> 27856573

Complete Genome Sequence of Lytic Bacteriophage LZ35 Infecting Acinetobacter baumannii Isolates.

Zhonghe Guo1, Honglan Huang1, Xiaolin Wu1, Yuchong Hao1, Yanbo Sun2.   

Abstract

Acinetobacter baumannii is a Gram-negative opportunistic pathogen that is frequently associated with nosocomial infections. Bacteriophages infecting A. baumannii can be used as effective agents to control these infections. Here, we announce the complete genome sequence of the lytic bacteriophage LZ35 infecting A. baumannii isolates.
Copyright © 2016 Guo et al.

Entities:  

Year:  2016        PMID: 27856573      PMCID: PMC5114365          DOI: 10.1128/genomeA.01104-16

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Acinetobacter baumannii, a nonfermentative, aerobic, Gram-negative bacillus, is a significant cause of opportunistic infections, such as ventilator-associated pneumonia, urinary tract infections, and bacteremia in intensive care units (1). Due to the increasing resistance to many classes of antibiotics among A. baumannii strains (2, 3), phage therapy (4, 5), an application of bacteriophages (phages) as an antibacterial agent, may be an alternative potential for controlling A. baumannii infection. Here, we present the complete genome sequence of lytic bacteriophage LZ35, which is infectious to A. baumannii. Bacteriophage LZ35 was isolated from sewage effluents from the Jilin University First-Affiliated Hospital. The morphology of LZ35 was determined using transmission electron microscopy and demonstrated a 47-nm head diameter and a 56-nm-long contractile tail, which are characteristics of members of the family Myoviridae. Phage DNA was sequenced in an Illumina MiSeq 250-bp paired-end run with a 546-bp insert library at Suzhou Genewiz Biological Technology Co., Ltd. (Suzhou, People’s Republic of China). After trimming with Trimmomatic (http://usadellab.org/cms/?page=trimmomatic) and removal of low-quality ends, 3,592,478 reads comprising a mean coverage of 17,647-fold were de-novo assembled using SSPACE (http://baseclear.com/genomics/bioinformatics/basetools/SSPACE) and GapFiller (http://baseclear.com/genomics/bioinformatics/basetools/gapfiller). Gene prediction and annotation of the phage LZ35 genome was performed using the RAST server (6). Phage LZ35 contained a 44,885-bp double-stranded DNA and a G+C content of 37.95%, with no tRNAs identified. A total of 83 coding sequences were identified. The analysis of the LZ35 genomic sequence reveals 78% and 77% matches with 97% and 99% identity to the Acinetobacter phage IME-AB2 (accession no. JX976549.1) (7) and Acinetobacter phage YMC-13-01-C62 (accession no. KJ817802.1) genomes, respectively. The genomic data of lytic phage LZ35 will prove useful for comparative studies and for the future investigation of LZ35 acting as a potential alternative for controlling A. baumannii infection.

Accession number(s).

The complete genome sequence of A. baumannii phage LZ35 has been submitted to the GenBank database under the accession number KU510289. The version described in this paper is the first version, KU510289.1.
  7 in total

Review 1.  Global challenge of multidrug-resistant Acinetobacter baumannii.

Authors:  Federico Perez; Andrea M Hujer; Kristine M Hujer; Brooke K Decker; Philip N Rather; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2007-07-23       Impact factor: 5.191

Review 2.  Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy.

Authors:  Elizabeth M Ryan; Sean P Gorman; Ryan F Donnelly; Brendan F Gilmore
Journal:  J Pharm Pharmacol       Date:  2011-07-06       Impact factor: 3.765

3.  Phage therapy gets revitalized.

Authors:  Sara Reardon
Journal:  Nature       Date:  2014-06-05       Impact factor: 49.962

Review 4.  Novel therapies for treatment of multi-drug resistant Acinetobacter baumannii skin infections.

Authors:  Mircea Radu Mihu; Luis R Martinez
Journal:  Virulence       Date:  2011-03-01       Impact factor: 5.882

Review 5.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

6.  The SEED and the Rapid Annotation of microbial genomes using Subsystems Technology (RAST).

Authors:  Ross Overbeek; Robert Olson; Gordon D Pusch; Gary J Olsen; James J Davis; Terry Disz; Robert A Edwards; Svetlana Gerdes; Bruce Parrello; Maulik Shukla; Veronika Vonstein; Alice R Wattam; Fangfang Xia; Rick Stevens
Journal:  Nucleic Acids Res       Date:  2013-11-29       Impact factor: 16.971

7.  Characterization, sequencing and comparative genomic analysis of vB_AbaM-IME-AB2, a novel lytic bacteriophage that infects multidrug-resistant Acinetobacter baumannii clinical isolates.

Authors:  Fan Peng; Zhiqiang Mi; Yong Huang; Xin Yuan; Wenkai Niu; Yahui Wang; Yuhui Hua; Huahao Fan; Changqing Bai; Yigang Tong
Journal:  BMC Microbiol       Date:  2014-07-05       Impact factor: 3.605

  7 in total
  1 in total

1.  Comparative Analysis of 37 Acinetobacter Bacteriophages.

Authors:  Dann Turner; Hans-Wolfgang Ackermann; Andrew M Kropinski; Rob Lavigne; J Mark Sutton; Darren M Reynolds
Journal:  Viruses       Date:  2017-12-24       Impact factor: 5.048

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.